Please Wait...

SCOPE Summit for Clinical Ops Executives

February 13, 2018 - 1:00am (EST) to February 15, 2018 - 1:00am (EST)

Bioclinica exhibit: Booth #521

 

SCOPE Track: Clinical Trial Forecasting, Budgeting and Contracting

Session Date and Time: Tuesday, February 13, 2018 at 3:20pm - 3:45pm

Speaker: Meghan Harrington, VP of Operations, Payments & Forecasting, Bioclinica

Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance

Bioclinica’s Meghan Harrington will present case studies showing how trial sponsors and CROs are automating the clinical payments process to improve accuracy and operational efficiency, while gaining greater control over cash management. Sponsors and CROs will see how to make accurate and timely decisions based on payment milestones, actuals and trends, plus how to quickly and accurately calculate accruals to track current liabilities for payments, ultimately becoming high-performing sites' ‘partner of choice’ by replacing error-prone, manual methods with fast and accurate data-driven processes.

 

SCOPE Track: RBM: where are we and what is next?

Session Date and Time: Thursday, February 15, 2018 at 11:35 am

Speaker: Kristin Mauri, Global Head of Risk-Based Monitoring, Bioclinica

The Past, Present and Future of RBM Technology

Kristin Mauri, Bioclinica’s Global Head of Risk-Based Monitoring, will discuss the impact of ICH E6 (R2), and how risk-based monitoring technologies have evolved to provide comprehensive support for required quality management improvements.

 

Stop by booth #521 to learn how Bioclinica has helped customers such as Johnson & Johnson, Fisher Clinical Services, Premier Research, FHI 360, and others bring clarity to clinical trials and develop new life-improving therapies efficiently and safely. We look forward to seeing you in sunny Orlando!

Event Website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SchulmanIRB: #FDA final rule requires #medicaldevice #research conducted outside US to conform with GCP standards | via @RAPSorg https:…
bioclinica (14 hours ago)
RT @manchempharma: Paul Brooks, Executive Director, @RAPSorg comments on Brexit and the operational trade and regulatory environment affect…
bioclinica (14 hours ago)
RT @eClinical_Jen: Clinical Data Management articles available on SCDM Website - While all articles are available to members, there are sel…
bioclinica (14 hours ago)
Live from Las Vegas where Bioclinica's Research Development Director Marieke Cajal, PhD, is presenting on site star… https://t.co/lVglg6NWdV
bioclinica (15 hours ago)
Many thanks all who attended @bioclinica's Executive Roundtable on Safety Mgmt for Pharma Cos in Japan in Tokyo th… https://t.co/OzHeSvHTUk
bioclinica (15 hours ago)
RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (17 hours ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen